| Michele Greenwood, AUD | |
|
217 W Cataldo Ave Fl 2, Spokane, WA 99201-2217 | |
| (509) 624-2326 | |
| (509) 744-3040 |
| Full Name | Michele Greenwood |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 11 Years |
| Location | 217 W Cataldo Ave Fl 2, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396912085 | NPI | - | NPPES |
| 0308036 | Other | WA | LABOR & INDUSTRIES |
| 2025210 | Medicaid | WA | |
| P00332903 | Other | WA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | LD00002170 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
News Archive
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
The Intermountain West is renowned for the beauty of its towering mountains and high deserts, but according to new research from an investigator with the University of Utah Brain Institute the region's lofty altitudes significantly influence a deadly problem: the high prevalence of suicides in this part of the country.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
› Verified 7 days ago
| Provider Name | Columbia Surgical Specialists, Ps |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417067372 PECOS PAC ID: 2860305505 Enrollment ID: O20031110000300 |
News Archive
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
The Intermountain West is renowned for the beauty of its towering mountains and high deserts, but according to new research from an investigator with the University of Utah Brain Institute the region's lofty altitudes significantly influence a deadly problem: the high prevalence of suicides in this part of the country.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
› Verified 7 days ago
| Provider Name | Providence Health & Services Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
The Intermountain West is renowned for the beauty of its towering mountains and high deserts, but according to new research from an investigator with the University of Utah Brain Institute the region's lofty altitudes significantly influence a deadly problem: the high prevalence of suicides in this part of the country.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele Greenwood, AUD Po Box 421, Liberty Lake, WA 99019-0421 Ph: (866) 747-2455 | Michele Greenwood, AUD 217 W Cataldo Ave Fl 2, Spokane, WA 99201-2217 Ph: (509) 624-2326 |
News Archive
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
The Intermountain West is renowned for the beauty of its towering mountains and high deserts, but according to new research from an investigator with the University of Utah Brain Institute the region's lofty altitudes significantly influence a deadly problem: the high prevalence of suicides in this part of the country.
Almost 10 per cent of bowel cancer patients die within a month of being diagnosed according to new analysis by the National Cancer Intelligence Network (NCIN), published today.
› Verified 7 days ago
Spokane Audiology Clinic, Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 801 W 5th Ave, Dmob Suite 112, Spokane, WA 99204 Phone: 509-835-5111 Fax: 509-835-5222 | |
Mcniven Hearing Centers Llc Audiologist Medicare: Medicare Enrolled Practice Location: 2309 N Division St Ste 1, Spokane, WA 99207 Phone: 509-993-6348 | |
Eastern Washington University Hearing And Speech Audiologist Medicare: Not Enrolled in Medicare Practice Location: 310 N Riverpoint Blvd, Spokane, WA 99202 Phone: 509-358-7581 Fax: 509-368-6890 | |
Kami Fehlig, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 217 W Cataldo Ave, Spokane, WA 99201 Phone: 509-624-2326 Fax: 509-744-3040 | |
Ms. Ronda K Kasper-braithwaite, AUD MA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 801 W 5th Ave, Suite 205, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 | |
Dr. Lesly Loiseau, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 801 W 5th Ave, Dmob Suite 112, Spokane, WA 99204 Phone: 509-835-5111 | |
Dr. Wendy Lucille Montgomery, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9222 N Newport Hwy Ste D, Spokane, WA 99218 Phone: 509-842-7382 Fax: 509-319-2511 |